Dr Farah Alsarraf Fellow presenting at CSEM Annual Scientific Meeting 2022
Aliya Khan, MD, FRCPC, FACP, FACE, FASBMR
Professor of Clinical Medicine
Aliya Khan is a Clinical Professor of Medicine in the Division of Endocrinology and Geriatrics at McMaster University, Director of the Calcium Disorders Clinic, and Director of the Fellowship in Metabolic Bone Disease at McMaster University. She graduated from the University of Ottawa Medical School with honors. She trained in Internal Medicine, Geriatric Medicine and Endocrinology and completed a fellowship in Metabolic Bone Disease at the University of Toronto. She has published over 400 scientific papers and numerous chapters and books on osteoporosis and parathyroid disease.
Dr. Khan led the development of global guidelines for parathyroid disease, osteonecrosis of the jaw, new diagnostic criteria for hypophosphatasia, treatment guidelines for X-linked hypophosphatemia in addition to Canadian guidelines for osteoporosis. She is the co-chair for developing international best practice recommendations on bone mineral density reporting supported by the 10 international scientific societies including ISCD, IOF, Radiologic Society of North America.
She is a clinician researcher and is the principal investigator evaluating novel therapies for parathyroid disease including PTH and PTH analogues as well PTH1receptor agonists for the treatment of hypoparathyroidism including palopegteriparatide, natpara, eneboparatide as well as the calcilytic molecule encalaret for the treatment of autosomal dominant hypocalcemia as well as cinacalcet for the medical management of primary hyperparathyroidism.
She has received numerous national and international awards including the Queen’s Diamond Jubilee Medalfor excellence, International Hypoparathyroidism Award, International Osteoporosis Foundation award for publishing excellence and recognized by Osteoporosis Canada for outstanding contributions to research and education. In 2024 she was the recipient of the Woman Physician of the Year Award by the American College of Physicians (ACP) honoring an outstanding woman physician with a distinguished career in areas of exceptional patient care, medical education and/or research. She also received the ACP Humanitarian of the Year Award given for outstanding contributions to humanism in medicine in 2024. In 2024 she received the Canadian Society of Endocrinology and Metabolism Dr. Jacques Genest Lecture Award. In December 2024 she was awarded the ORTOMED Medal from the Italian Society of Ortopedia e Medicina for outstanding contributions to metabolic bone disease.
She is recognized as being in the top 0.1% of the world experts in hyperparathyroidism by Expertscape.
Dr. Sarah Khan
MD
Dr Sarah Khan MD FRPC is a staff clinician at the Bone Research and Education Clinic (BREC) and at Credit Valley Hospital (Trillium Health Partners). She graduated from the University of Toronto School of Medicine in 2015. She went on to complete her Internal Medicine Residency and Endocrinology Fellowship at the University of Toronto (UofT) as well. She has a keen interest in treating patients with metabolic bone diseases at BREC. Outside of clinical work she is actively partaking as a co-investigator in clinical trials to investigate new treatment options for patients with hypoparathyroidism. She is also pursing her Master of Education at the Ontario Institute of Studies in Education (OISE) at UofT.
Dr. Lora Giangregorio
Kinesiologist
Lora Giangregorio, PhD is a Professor and Tier 1 Canada Research Chair in Bone Health and Exercise Science in the Department of Kinesiology and Health Sciences at the University of Waterloo. She leads the Bone Health and Exercise Science Lab, or BonES lab. The BonES lab team leads research on physical activity for fall and fracture prevention. Dr. Giangregorio is a member of the Scientific Advisory Council for Osteoporosis Canada and was on the leadership team that developed the 2020 Canadian 24-hour Movement Guidelines. She also led the Exercise Working Group for the 2023 Clinical Practice Guidelines for Management of Osteoporosis and Fracture Prevention in Canada.
Endocrine Society 2023: Dr. Aliya Khan and Dr. Sarah Khan
